GF

Gujarat Fluorochemicals Ltd

Q4 FY26Chemicals & Petrochemicals

Gujarat Fluorochemicals Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹4,622
Market cap₹52.0K Cr
P/E84.3
Updated23 Aug 2026
Read4 min read

The short version

EBITDA growth is expected alongside volume growth, driven by higher margin products. EBITDA growth is expected alongside volume growth due to higher-margin products (Page 15).

From Gujarat Fluorochemicals Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • EBITDA growth is expected alongside volume growth, driven by higher margin products. (Page 15)
  • Significant quarter-on-quarter revenue growth anticipated in battery chemicals, reaching a 3-digit crore exit rate by Q4 FY '27. (Page 15)
  • Refrigerant (R-32) capacity ramp-up to 20,000 tons expected, with contracted sales and no selling challenges. Revenue growth to follow capacity scaling. (Page 14)
  • Fluoropolymers business will see volume and EBITDA growth as capacity utilization approaches optimum and new higher-value polymers are added. (Page 14)
  • Battery materials business ramping up with commercial sales starting for LiPF6 salt and cathode active materials; revenues to grow quarter-on-quarter. (Pages 12-13)

2 more points management made on revenue & sales performance

Profitability & Margins

See what Gujarat Fluorochemicals Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • INR 850 crores capex planned for FY '27 on chemical side:
  • INR 150 crores for expanding refrigerant gas (R-32) capacity to 20,000 tons.
  • INR 222 crores for new high-purity electronic specialty chemicals (semiconductor sector).
  • INR 250 crores for new fluoropolymer capacities (focusing on new fluoropolymers).
  • INR 230 crores on backward integration and maintenance.
  • INR 2,300 crores capex planned for FY '27 on EV battery materials:
  • Capacity expansions across existing battery material products including LiPF6 salt and LFP cathode active material.
  • New natural graphite anode active material facility.
  • This is part of a cumulative INR 6,000 crores capex planned for battery materials by FY '28.
  • Oman project capex proceeding as planned, unaffected by Middle East geopolitical issues.

2 more points management made on capital expenditure plans

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

5x potential
1Shiv Texchem
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Gujarat Fluorochemicals Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • All initial capacities under Phase One of the battery materials business have been commissioned and contracted for.
  • Marquee anchor customers secured across all battery material products, providing confidence on utilization ramp-up.
  • LiPF6 salt has approvals from most major global electrolyte players; commercial sales scaling in line with plans.
  • Orders are in place for FY '27 and beyond, with production expected to ramp up quarter-on-quarter.
  • Cathode active material samples received initial approval; final qualification expected by Q3 FY '27, with off-take agreements for entire capacity.
  • The natural graphite anode active material facility is planned, further expanding product portfolio and order potential.
  • For R-32 refrigerant, the current 10,000-ton capacity is commissioned and operating at optimal levels with contracts in place.

2 more points management made on order book & pipeline

Gujarat Fluorochemicals Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹1.4K Cr, net profit ₹109 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Vipul Organics Ltd (Q4 FY26)

    Q4 FY26 (Mar 2026) total revenue: ₹5,262.37 lakhs (Consolidated) . Key concall takeaways from Vipul Organics's Q4 FY26 earnings call — and how it ranks against…

  • Chemfab Alkalis Ltd (Q4 FY26)

    Chlor Alkali segment: ₹55.63 crore (down 1.21% YoY from ₹56.31 crore) . Key concall takeaways from Chemfab Alkalis Ltd's Q4 FY26 earnings call — and how it…

  • Sudarshan Pharma Industries Ltd (Q4 FY26)

    Revenue from Operations for Q4 March 2026: ₹220.92 Cr (Page 41) . Key concall takeaways from Sudarshan Pharma Industries Ltd's Q4 FY26 earnings call — and how…

  • Innovassynth Technologies (India) Ltd (Q4 FY26)

    Order book improved by approximately INR 60 crore during the quarter, indicating strong customer demand and revenue visibility. Key concall takeaways from…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Gujarat Fluorochemicals Ltd Q4 FY26 results?

EBITDA growth is expected alongside volume growth, driven by higher margin products. EBITDA growth is expected alongside volume growth due to higher-margin products (Page 15).

What is Gujarat Fluorochemicals Ltd share price analysis?

Gujarat Fluorochemicals Ltd currently shows a neutral. The stock trades at a P/E of 84.3 with a market cap of ₹52,045 Cr. Investors should review the full earnings analysis for detailed insights.

Is Gujarat Fluorochemicals Ltd planning capital expenditure?

INR 850 crores capex planned for FY '27 on chemical side: - INR 150 crores for expanding refrigerant gas (R-32) capacity to 20,000 tons.

Keep Gujarat Fluorochemicals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.